Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAPROPTERIN vs SARGRAMOSTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAPROPTERIN vs SARGRAMOSTIM: Safety Overview

Metric SAPROPTERIN SARGRAMOSTIM
Total FAERS Reports 5,539 593
Deaths Reported 60 85
Death Rate 1.1% 14.3%
Hospitalizations 339 138
Average Patient Age 23.3 yrs 34.4 yrs
% Female Patients 61.6% 43.5%
FDA Approval Date Apr 29, 2025 N/A
Manufacturer Dr. Reddys Laboratories Inc Partner Therapeutics, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription